The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life
Roy FleischmannMetroplex Clinical Research Center, Dallas, Texas, USAAbstract: Rheumatoid arthritis can cause chronic pain, disability, fatigue and loss of productivity both in the workplace and at home. Fatigue, not joint pain, swelling or that there may be radiographic damage, is frequently mentio...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-07-01
|
| Series: | Open Access Rheumatology : Research and Reviews |
| Online Access: | http://www.dovepress.com/the-clinical-efficacy-and-safety-of-certolizumab-pegol-czp-in-the-trea-a3356 |